ORAMED PHARMACEUTICALS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $11.4M | $128.0M | $77.2M |
| FY2022 | $9.8M | $161.6M | $40.5M |
| FY2023 | $56.7M | $220.6M | $9.1M |
| FY2024 | $9.0M | $155.3M | $54.4M |
| FY2025 | $31.1M | $230.9M | $45.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $11.4M | $128.0M | $77.2M |
| FY2022 | $9.8M | $161.6M | $40.5M |
| FY2023 | $56.7M | $220.6M | $9.1M |
| FY2024 | $9.0M | $155.3M | $54.4M |
| FY2025 | $31.1M | $230.9M | $45.9M |